Abstract
A 62-year-old woman was diagnosed with severe osteomalacia caused by renal tubular acidosis associated with Sjögren's syndrome. She was treated with sodium bicarbonate, risedronate, alfacalcidol, and prednisolone (1 mg/kg). By 24 months, renal tubular acidosis was improved and the bone density had normalized. Here we report the successful amelioration of bone lesions through a multidisciplinary approach that improved renal tubular acidosis, with a special focus on treatment of the underlying inflammatory disorder with glucocorticoids.
MeSH terms
-
Acidosis, Renal Tubular / complications*
-
Bone Density Conservation Agents / therapeutic use*
-
Drug Therapy, Combination
-
Etidronic Acid / analogs & derivatives
-
Etidronic Acid / therapeutic use
-
Female
-
Glucocorticoids / therapeutic use
-
Humans
-
Hydroxycholecalciferols / therapeutic use
-
Middle Aged
-
Osteomalacia / drug therapy*
-
Osteomalacia / etiology
-
Prednisolone / therapeutic use
-
Risedronic Acid
-
Sjogren's Syndrome / complications*
-
Sodium Bicarbonate / therapeutic use
-
Treatment Outcome
Substances
-
Bone Density Conservation Agents
-
Glucocorticoids
-
Hydroxycholecalciferols
-
Sodium Bicarbonate
-
Prednisolone
-
Risedronic Acid
-
Etidronic Acid
-
alfacalcidol